Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Farmers Insurance
Johnson and Johnson
Boehringer Ingelheim

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050723

« Back to Dashboard
NDA 050723 describes CELLCEPT, which is a drug marketed by Roche Palo and is included in four NDAs. It is available from four suppliers. Additional details are available on the CELLCEPT profile page.

The generic ingredient in CELLCEPT is mycophenolate mofetil hydrochloride. There are thirty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mycophenolate mofetil hydrochloride profile page.

Summary for NDA: 050723

Formulation / Manufacturing:see details

Pharmacology for NDA: 050723

Suppliers and Packaging for NDA: 050723

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
mycophenolate mofetil
TABLET;ORAL 050723 NDA Genentech, Inc. 0004-0260 0004-0260-01 1 BOTTLE, PLASTIC in 1 CARTON (0004-0260-01) > 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
mycophenolate mofetil
TABLET;ORAL 050723 NDA Genentech, Inc. 0004-0260 0004-0260-43 1 BOTTLE, PLASTIC in 1 CARTON (0004-0260-43) > 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jun 19, 1997TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 050723

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo
mycophenolate mofetil
TABLET;ORAL050723-001Jun 19, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts
Queensland Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus